Related Experiment Video
Updated: Jan 1, 2026

The Inverted Heart Model for Interstitial Transudate Collection from the Isolated Rat Heart
Published on: June 20, 2017
Emergence of Chloride as an Overlooked Cardiorenal Connector in Heart Failure
Amir Kazory1, Claudio Ronco2,3
1Division of Nephrology, Hypertension, and Renal Transplantation, University of Florida, Gainesville, Florida, USA, amir.kazory@medicine.ufl.edu.
Insights
Emerging research suggests serum chloride, not just sodium, is a key predictor of outcomes in heart failure (HF) and cardiorenal syndrome. Low chloride levels may indicate worse prognosis and offer new therapeutic targets.
Area of Science:
- Cardiology
- Nephrology
- Clinical Biochemistry
Background:
- Traditional heart failure (HF) management focused on sodium restriction.
- Recent studies challenge the consistent benefits of severe salt restriction in HF.
- Paradoxical adverse outcomes are observed with very low salt intake in advanced HF.
Purpose of the Study:
- To review the emerging role of serum chloride in cardiorenal syndrome.
- To explore chloride's prognostic value compared to sodium in HF.
- To discuss potential mechanisms and therapeutic implications of chloride levels in HF.
Main Methods:
- Review of contemporary studies and emerging data on serum chloride in HF.
- Analysis of mechanistic links between hypochloremia and HF pathophysiology.
- Exploration of clinical relevance and interpretation of chloride's prognostic role.
Main Results:
- Serum chloride levels show significant independent prognostic value in various HF syndromes.
- Hypochloremia is linked to adverse outcomes, potentially via renal tubular dysfunction and neurohormonal activation.
- Chloride's prognostic impact may exceed that of sodium in certain HF populations.
Conclusions:
- Serum chloride is a critical cardiorenal connector, challenging the sodium-centric view in HF.
- Hypochloremia represents a potential therapeutic target for improving HF outcomes.
- Future strategies for HF management should consider chloride levels for improved prediction and treatment.
Abstract:
Several studies have recently challenged the sodium-centric view that has been dominating the field of heart failure (HF) and cardiorenal syndrome. The previously observed benefits of severe dietary restriction of salt do not seem to be consistently reproduced by contemporary studies. Moreover, there is evidence that too low intake may paradoxically lead to adverse outcomes in more advanced stages of HF. Facing the escalating controversy, investigators have shifted their focus from sodium to its often overlooked counter ion in salt, the chloride. Emerging data suggest that serum chloride levels could portend robust independent prognostic value in a wide range of HF syndromes possibly stronger than that of sodium. The untoward impact of hypochloremia on the outcomes could be mechanistically linked to renal tubular regulatory pathways, neurohormonal activation, and diuretic resistance. As such, it can be a potential target of therapy in this setting. In this article, the authors provide a brief overview of the role of serum chloride as a cardiorenal connector and explore the context in which the contemporary data should be interpreted. Implementation of predictive and therapeutic strategies incorporating the emerging evidence would be refined through discussion of nuances of such findings as well as their biological and clinical relevance.
Related Concept Videos
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure VI: Adjunct Therapies
Heart Failure II: Pathophysiology
Heart Failure III: Clinical Manifestations
Mitral Regurgitation I: Introduction
